Turakhia: FDA's Digital Health Office effectively mitigates regulatory risk
Mintu Turakhia · a16z Podcast | Putting AI in Medicine, in Practice · Jan 2, 2019 · at 21:46
Dr. Mintu Turakhia evaluates regulatory hurdles and institutional adoption incentives for digital health devices and software.
0:00 / 0:07exact quote · 7.5s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“The regulatory risk thing is being largely addressed by this new Office of Digital Health and the FDA, and they're really doing, seem much more forward thinking about it.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Mintu Turakhia
Turakhia: Fully autonomous medical AI faces societal, not technical, barriers
“That's a societal issue. That's not a technical hurdle at this point.”
Turakhia: Continuous learning in medical AI risks patient harm from biased data
“Bad data could heavily bias the system and cause harm, right? So if you start learning from bad inputs that come into the system for whatever reason, you could intentionally or unintentionally, you know, cause harm.”
Turakhia: Missing wearable data is the strongest predictor of illness
“In fact, the biggest predictor, Of someone getting ill with a lot of wearable studies is missing data because they were too sick to wear the sensor.”
Turakhia: AI cannot predict acute heart attacks days in advance
“You can predict a cumulative probability, like a probability of getting condition X or diagnosis X over a time horizon of five or 10 years. But we are nowhere near saying, you know, you're going to have a heart attack in the next three days.”